IFNA1 and systemic lupus erythematosus: Systemic lupus erythematosus (SLE) is a common autoimmune disease, characterised by chronic immune activation including a systemic type I interferon (IFN)-induced transcriptional signature in blood (henceforth referred to as the IFN signature), and the development of anti-nucleic acid autoantibodies1,2.